Following the worldwide declaration of the COVID-19 pandemic in early 2020, healthcare embraced digital and telehealth solutions in order to maintain oversight and delivery of patient care. Cancer care was certainly not insulated from this. Fairly soon after the pandemic began, most countries with well-developed health systems began to try and balance the need to continue to treat cancers, sometimes urgently, against the requirement to minimise exposure of patients and hospital staff to SARS-CoV-2 infection. Two years after the emergence of the novel coronavirus, this chapter appraises the widespread use of digital technology in cancer care, the effectiveness of this and the overall effect on patient experience.